Albert Bourla, Pfizer chairman and CEO, joins CNBC's 'Power Lunch' to discuss the company's focus for 2025, whether bird flu is the next pandemic, and more.

Trump says he wants to “reshore” U.S. companies, bringing their business activities and tax dollars back home. That would be ...

Varenicline works very differently to Nicotine Replacement Therapy, for a long time the de facto solution for serious smokers ...

And regular polling carried out by YouGov suggests adults are increasingly likely to say that vaccines have harmful side effects that are not being disclosed to the public. The proportion saying that ...

Raised in Grand Rapids, Marsha attended Lee and Kentwood High Schools, where she developed a love for performance. As a baton ...

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...

Triplex has been purchased by a firm named Gecom International Pvt Ltd in a building named Signature Island in BKC area of ...

Four years from now, what might we be saying about what we just lived through? The possibilities seem endless.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

On Jan 15, Pfizer Inc. ( PFE, Financial) announced to sale of about 700 million ordinary shares of Haleon plc through a ...

Pfizer is expected to rebound in 2025 with growth stabilized and dividend growth to continue. Learn why PFE stock is a Buy.